Zealand Pharma A/S

ZEAL

Equity

ISIN DK0060257814 / Valor 11983050

Nasdaq Copenhagen Equities (2026-02-27)

DKK 363.80+1.06%

Zealand Pharma A/S
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Zealand Pharma A/S is a biotechnology company based in Denmark, specializing in the development of peptide-based therapeutics. The company focuses on creating innovative treatments for diseases with significant unmet medical needs, particularly in areas where peptide therapies can offer substantial benefits. Zealand Pharma is actively engaged in addressing major health challenges such as obesity and its related complications, including cardiovascular and liver diseases, type 2 diabetes, and neuroinflammation. Additionally, the company is exploring the potential of peptide medicines in treating chronic inflammatory diseases, aiming to provide new solutions for conditions that can lead to severe health issues. Through its research and development efforts, Zealand Pharma seeks to deliver differentiated product candidates that can improve patient outcomes in these critical areas.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-47.7%1Y

59.0%3Y

86.4%5Y

Performance

66.1%1Y

57.5%3Y

55.8%5Y

Volatility